Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer

TMPRSS2-ERG junction oncogene is present in more than 50% of patients with prostate cancer and its expression is frequently associated with poor prognosis. Our aim is to achieve gene knockdown by siRNA TMPRSS2-ERG and then to assess the biological consequences of this inhibition. First, we designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbinati, Giorgia, Ali, Hafiz Muhammad, Rousseau, Quentin, Chapuis, Hubert, Desmaële, Didier, Couvreur, Patrick, Massaad-Massade, Liliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416711/
https://www.ncbi.nlm.nih.gov/pubmed/25933120
http://dx.doi.org/10.1371/journal.pone.0125277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416711/
https://www.ncbi.nlm.nih.gov/pubmed/25933120
http://dx.doi.org/10.1371/journal.pone.0125277

Ejemplares similares